{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:16:48Z","timestamp":1790709408504,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatoblastoma (HB) is the most common hepatic neoplasm in childhood and the therapeutic outcomes remain undesirable due to its recurrence and metastasis. Increasing evidence shows that dipeptidase 1 (DPEP1) has pivotal function in tumorigenesis in multiple tumors. However, the expression pattern, biological function, and underlying mechanism of DPEP1 in HB have not been reported. Here we showed that DPEP1 was significantly upregulated and was associated with poor prognosis in HB patients. In vitro and in vivo assays indicated that silencing DPEP1 significantly suppressed HB cell proliferation, migration, and invasion, while DPEP1 overexpression exhibited the opposite effect. In addition, we identified that DPEP1 was a direct target of microRNA-193a-5p (miR-193a-5p). Functional experiments demonstrated that overexpression of miR-193a-5p significantly inhibited cell proliferation and invasion of HB cells, while the inhibitory effect could be reversed by DPEP1 overexpression. Moreover, miR-193a-5p was decreased in HB tumor tissues and associated with a poor clinical prognosis. Mechanistically, our results indicated that the miR-193a-5p\/DPEP1 axis participated to the progression of HB via regulating the PI3K\/Akt\/mTOR (phosphatidylinositol-3-kinase\/Akt\/mammalian target of rapamycin) signaling. In conclusion, our findings suggest that the miR-193a-5p \/DPEP1 axis might be a good prognostic predictor and therapeutic target in HB.<\/jats:p>","DOI":"10.1038\/s41419-019-1943-0","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T07:17:43Z","timestamp":1568963863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K\/Akt\/mTOR pathway"],"prefix":"10.1038","volume":"10","author":[{"given":"Xichun","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qicai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"1943_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/pbc.24213","volume":"59","author":"GE Tomlinson","year":"2012","unstructured":"Tomlinson, G. E. & Kappler, R. Genetics and epigenetics of hepatoblastoma. Pediatr. Blood Cancer 59, 785\u2013792 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"1943_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4254\/wjh.v6.i7.486","volume":"6","author":"I Fernandez-Pineda","year":"2014","unstructured":"Fernandez-Pineda, I. & Cabello-Laureano, R. Differential diagnosis and management of liver tumors in infants. World J. Hepatol. 6, 486\u2013495 (2014).","journal-title":"World J. Hepatol."},{"key":"1943_CR3","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","volume":"127","author":"FX Bosch","year":"2004","unstructured":"Bosch, F. X., Ribes, J., Diaz, M. & Cleries, R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127, S5\u2013S16 (2004).","journal-title":"Gastroenterology"},{"key":"1943_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/HMER.S89997","volume":"9","author":"AD Trobaugh-Lotrario","year":"2017","unstructured":"Trobaugh-Lotrario, A. D., Meyers, R. L., O\u2019Neill, A. F. & Feusner, J. H. Unresectable hepatoblastoma: current perspectives. Hepat. Med. 9, 1\u20136 (2017).","journal-title":"Hepat. Med."},{"key":"1943_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/0971-9261.142001","volume":"19","author":"DC Aronson","year":"2014","unstructured":"Aronson, D. C., Czauderna, P., Maibach, R., Perilongo, G. & Morland, B. The treatment of hepatoblastoma: its evolution and the current status as per the SIOPEL trials. J. Indian Assoc. Pediatr. Surg. 19, 201\u2013207 (2014).","journal-title":"J. Indian Assoc. Pediatr. Surg."},{"key":"1943_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00535-010-0318-1","volume":"46","author":"Y Toiyama","year":"2011","unstructured":"Toiyama, Y. et al. DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness. J. Gastroenterol. 46, 153\u2013163 (2011).","journal-title":"J. Gastroenterol."},{"key":"1943_CR7","first-page":"423","volume":"6","author":"K Tachibana","year":"2017","unstructured":"Tachibana, K. et al. Clinicopathological examination of dipeptidase 1 expression in colorectal cancer. Biomed. Rep. 6, 423\u2013428 (2017).","journal-title":"Biomed. Rep."},{"key":"1943_CR8","doi-asserted-by":"crossref","first-page":"9501","DOI":"10.18632\/oncotarget.7033","volume":"7","author":"SY Park","year":"2016","unstructured":"Park, S. Y. et al. Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer. Oncotarget 7, 9501\u20139512 (2016).","journal-title":"Oncotarget"},{"key":"1943_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10549-008-9905-8","volume":"113","author":"AR Green","year":"2009","unstructured":"Green, A. R. et al. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast. Breast Cancer Res. Treat. 113, 59\u201366 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"1943_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb0309-228","volume":"11","author":"J Winter","year":"2009","unstructured":"Winter, J., Jung, S., Keller, S., Gregory, R. I. & Diederichs, S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228\u2013234 (2009).","journal-title":"Nat. Cell Biol."},{"key":"1943_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834\u2013838 (2005).","journal-title":"Nature"},{"key":"1943_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cancers11030409","volume":"11","author":"I Cristobal","year":"2019","unstructured":"Cristobal, I. et al. The role of microRNAs in hepatoblastoma tumors. Cancers 11, 409 (2019).","journal-title":"Cancers"},{"key":"1943_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00383-016-3960-8","volume":"32","author":"W Liu","year":"2016","unstructured":"Liu, W., Chen, S. & Liu, B. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatr. Surg. Int. 32, 1059\u20131065 (2016).","journal-title":"Pediatr. Surg. Int."},{"key":"1943_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MPH.0000000000001234","volume":"41","author":"CO Ecevit","year":"2019","unstructured":"Ecevit, C. O. et al. MicroRNA-17, microRNA-19b, microRNA-146a, microRNA-302d expressions in hepatoblastoma and clinical importance. J. Pediatr. Hematol. Oncol. 41, 7\u201312 (2019).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"1943_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.24125","volume":"53","author":"J von Frowein","year":"2011","unstructured":"von Frowein, J. et al. MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology 53, 833\u2013842 (2011).","journal-title":"Hepatology"},{"key":"1943_CR16","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.21873\/anticanres.12596","volume":"38","author":"NH Chou","year":"2018","unstructured":"Chou, N. H. et al. MiR-193a-5p and -3p play a distinct role in gastric cancer: miR-193a-3p suppresses gastric cancer cell growth by targeting ETS1 and CCND1. Anticancer Res. 38, 3309\u20133318 (2018).","journal-title":"Anticancer Res."},{"key":"1943_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s12253-018-0392-x","volume":"24","author":"X Ren","year":"2018","unstructured":"Ren, X. et al. Diagnostic model of serum miR-193a-5p, HE4 and CA125 improves the diagnostic efficacy of epithelium ovarian cancer. Pathol. Oncol. Res. 24, 739\u2013744 (2018).","journal-title":"Pathol. Oncol. Res."},{"key":"1943_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13046-017-0649-3","volume":"36","author":"Z Yang","year":"2017","unstructured":"Yang, Z. et al. Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. J. Exp. Clin. Cancer Res. 36, 178 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1943_CR19","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.3748\/wjg.v20.i34.12241","volume":"20","author":"P Zhang","year":"2014","unstructured":"Zhang, P. et al. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. World J. Gastroenterol. 20, 12241\u201312248 (2014).","journal-title":"World J. Gastroenterol."},{"key":"1943_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/bjc.2013.363","volume":"109","author":"PA Eisenach","year":"2013","unstructured":"Eisenach, P. A. et al. Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer. Br. J. Cancer 109, 694\u2013703 (2013).","journal-title":"Br. J. Cancer"},{"key":"1943_CR21","doi-asserted-by":"publisher","first-page":"e0185565","DOI":"10.1371\/journal.pone.0185565","volume":"12","author":"F Xie","year":"2017","unstructured":"Xie, F. et al. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1. PLoS ONE 12, e0185565 (2017).","journal-title":"PLoS ONE"},{"key":"1943_CR22","doi-asserted-by":"crossref","first-page":"39680","DOI":"10.18632\/oncotarget.9444","volume":"7","author":"CH Lin","year":"2016","unstructured":"Lin, C. H. et al. MiR-193a-5p\/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma. Oncotarget 7, 39680\u201339693 (2016).","journal-title":"Oncotarget"},{"key":"1943_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/onc.2013.574","volume":"34","author":"T Yu","year":"2015","unstructured":"Yu, T. et al. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4\/PIK3R3\/mTOR\/S6K2 signaling pathway. Oncogene 34, 413\u2013423 (2015).","journal-title":"Oncogene"},{"key":"1943_CR24","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1242\/dev.137075","volume":"143","author":"JS Yu","year":"2016","unstructured":"Yu, J. S. & Cui, W. Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination. Development 143, 3050\u20133060 (2016).","journal-title":"Development"},{"key":"1943_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.soc.2013.06.008","volume":"22","author":"B Hassan","year":"2013","unstructured":"Hassan, B., Akcakanat, A., Holder, A. M. & Meric-Bernstam, F. Targeting the PI3-kinase\/Akt\/mTOR signaling pathway. Surg. Oncol. Clin. N. Am. 22, 641\u2013664 (2013).","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"1943_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2217\/fon.11.95","volume":"7","author":"Q Zhou","year":"2011","unstructured":"Zhou, Q., Lui, V. W. & Yeo, W. Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma. Fut. Oncol. 7, 1149\u20131167 (2011).","journal-title":"Fut. Oncol."},{"key":"1943_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.biopha.2009.06.007","volume":"64","author":"R Guo","year":"2010","unstructured":"Guo, R. et al. Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2. Biomed. Pharmacother. 64, 249\u2013253 (2010).","journal-title":"Biomed. Pharmacother."},{"key":"1943_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0527-9","volume":"32","author":"X Li","year":"2015","unstructured":"Li, X. et al. Effect of baicalin-copper on the induction of apoptosis in human hepatoblastoma cancer HepG2 cells. Med. Oncol. 32, 72 (2015).","journal-title":"Med. Oncol."},{"key":"1943_CR29","doi-asserted-by":"publisher","first-page":"e0147405","DOI":"10.1371\/journal.pone.0147405","volume":"11","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Polyphyllin VII induces an autophagic cell death by activation of the JNK pathway and inhibition of PI3K\/AKT\/mTOR pathway in HepG2 Cells. PLoS ONE 11, e0147405 (2016).","journal-title":"PLoS ONE"},{"key":"1943_CR30","doi-asserted-by":"publisher","first-page":"e12510","DOI":"10.1111\/cpr.12510","volume":"51","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma. Cell Prolif. 51, e12510 (2018).","journal-title":"Cell Prolif."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1943-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1943-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1943-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T12:35:27Z","timestamp":1671194127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1943-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1943-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"assertion":[{"value":"29 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"701"}}